NCT06364176View on ClinicalTrials.gov

Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.

PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

October 31, 2027

Conditions
Cystic Fibrosis
Interventions
DRUG

Losartan

Treatment with losartan through week 12

DRUG

Placebo

Treatment with placebo through week 12

Trial Locations (1)

66160

RECRUITING

University of Kansas Medical Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER